Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech

on Wednesday, 3 September 2014 include new market research report " Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

The report provides a detailed understanding and analysis of how and why companies enter preclinical stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

View Full Report with TOC at:

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all preclinical stage partnering deals announced since 2009 including financial terms where available including over 2,000 links to online deal records of actual preclinical partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

Browse More related reports to Pharmaceuticals at:

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech provides the reader with the following key benefits:
  • In-depth understanding of preclinical stage deal trends since 2009
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to over 2,000 preclinical stage deals together with contract documents if available
  • Detailed access to actual preclinical stage deals entered into by the leading fifty big pharma and big biotech companies along with other biopharma companies
  • Analysis of the structure of preclinical stage agreements with numerous real life case studies
  • Identify leading preclinical stage deals by value since 2009
  • Identify the most active preclinical stage dealmakers since 2009
  • Full listing of preclinical stage deals by company A-Z, phase of development, deal type, therapy and technology focus
  • Understand the key deal terms companies have agreed in previous deals          
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

About Us:

ResearchMoz ( ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mrs.Sheela AK
Toll Free: 866-997-4948


Post a Comment